Ravgen is a biotechnology company focused on prenatal diagnostic testing. It is focused on developing non-invasive prenatal diagnostic tests based on fetal DNA present in maternal blood. Ravgen’s technology allows for non-invasive prenatal genetic testing for single-gene disorders and chromosomal abnormalities, such as CF, SMA, and sickle cell anemia.